Report Detail

Medical Devices & Consumables Global Imaging In Clinical Trials Market Size, Status and Forecast 2021-2027

  • RnM4281761
  • |
  • 28 January, 2021
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Imaging In Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Services
    • 1.2.3 Software
  • 1.3 Market by Application
    • 1.3.1 Global Imaging In Clinical Trials Market Share by End Users: 2016 VS 2021 VS 2027
    • 1.3.2 Biotechnology Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Medical Device Manufacturers
    • 1.3.5 Government and Academic Institutions
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Imaging In Clinical Trials Market Perspective (2016-2027)
  • 2.2 Imaging In Clinical Trials Growth Trends by Regions
    • 2.2.1 Imaging In Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Imaging In Clinical Trials Historic Market Share by Regions (2016-2021)
    • 2.2.3 Imaging In Clinical Trials Forecasted Market Size by Regions (2022-2027)
  • 2.3 Imaging In Clinical Trials Industry Dynamic
    • 2.3.1 Imaging In Clinical Trials Market Trends
    • 2.3.2 Imaging In Clinical Trials Market Drivers
    • 2.3.3 Imaging In Clinical Trials Market Challenges
    • 2.3.4 Imaging In Clinical Trials Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Imaging In Clinical Trials Players by Revenue
    • 3.1.1 Global Top Imaging In Clinical Trials Players by Revenue (2016-2021)
    • 3.1.2 Global Imaging In Clinical Trials Revenue Market Share by Players (2016-2021)
  • 3.2 Global Imaging In Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Imaging In Clinical Trials Revenue
  • 3.4 Global Imaging In Clinical Trials Market Concentration Ratio
    • 3.4.1 Global Imaging In Clinical Trials Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Imaging In Clinical Trials Revenue in 2020
  • 3.5 Imaging In Clinical Trials Key Players Head office and Area Served
  • 3.6 Key Players Imaging In Clinical Trials Product Solution and Service
  • 3.7 Date of Enter into Imaging In Clinical Trials Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Imaging In Clinical Trials Breakdown Data by Type

  • 4.1 Global Imaging In Clinical Trials Historic Market Size by Type (2016-2021)
  • 4.2 Global Imaging In Clinical Trials Forecasted Market Size by Type (2022-2027)

5 Imaging In Clinical Trials Breakdown Data by End Users

  • 5.1 Global Imaging In Clinical Trials Historic Market Size by End Users (2016-2021)
  • 5.2 Global Imaging In Clinical Trials Forecasted Market Size by End Users (2022-2027)

6 North America

  • 6.1 North America Imaging In Clinical Trials Market Size (2016-2027)
  • 6.2 North America Imaging In Clinical Trials Market Size by Type
    • 6.2.1 North America Imaging In Clinical Trials Market Size by Type (2016-2021)
    • 6.2.2 North America Imaging In Clinical Trials Market Size by Type (2022-2027)
    • 6.2.3 North America Imaging In Clinical Trials Market Size by Type (2016-2027)
  • 6.3 North America Imaging In Clinical Trials Market Size by End Users
    • 6.3.1 North America Imaging In Clinical Trials Market Size by End Users (2016-2021)
    • 6.3.2 North America Imaging In Clinical Trials Market Size by End Users (2022-2027)
    • 6.3.3 North America Imaging In Clinical Trials Market Size by End Users (2016-2027)
  • 6.4 North America Imaging In Clinical Trials Market Size by Country
    • 6.4.1 North America Imaging In Clinical Trials Market Size by Country (2016-2021)
    • 6.4.2 North America Imaging In Clinical Trials Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Imaging In Clinical Trials Market Size (2016-2027)
  • 7.2 Europe Imaging In Clinical Trials Market Size by Type
    • 7.2.1 Europe Imaging In Clinical Trials Market Size by Type (2016-2021)
    • 7.2.2 Europe Imaging In Clinical Trials Market Size by Type (2022-2027)
    • 7.2.3 Europe Imaging In Clinical Trials Market Size by Type (2016-2027)
  • 7.3 Europe Imaging In Clinical Trials Market Size by End Users
    • 7.3.1 Europe Imaging In Clinical Trials Market Size by End Users (2016-2021)
    • 7.3.2 Europe Imaging In Clinical Trials Market Size by End Users (2022-2027)
    • 7.3.3 Europe Imaging In Clinical Trials Market Size by End Users (2016-2027)
  • 7.4 Europe Imaging In Clinical Trials Market Size by Country
    • 7.4.1 Europe Imaging In Clinical Trials Market Size by Country (2016-2021)
    • 7.4.2 Europe Imaging In Clinical Trials Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Imaging In Clinical Trials Market Size (2016-2027)
  • 8.2 Asia-Pacific Imaging In Clinical Trials Market Size by Type
    • 8.2.1 Asia-Pacific Imaging In Clinical Trials Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Imaging In Clinical Trials Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Imaging In Clinical Trials Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Imaging In Clinical Trials Market Size by End Users
    • 8.3.1 Asia-Pacific Imaging In Clinical Trials Market Size by End Users (2016-2021)
    • 8.3.2 Asia-Pacific Imaging In Clinical Trials Market Size by End Users (2022-2027)
    • 8.3.3 Asia-Pacific Imaging In Clinical Trials Market Size by End Users (2016-2027)
  • 8.4 Asia-Pacific Imaging In Clinical Trials Market Size by Region
    • 8.4.1 Asia-Pacific Imaging In Clinical Trials Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Imaging In Clinical Trials Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Imaging In Clinical Trials Market Size (2016-2027)
  • 9.2 Latin America Imaging In Clinical Trials Market Size by Type
    • 9.2.1 Latin America Imaging In Clinical Trials Market Size by Type (2016-2021)
    • 9.2.2 Latin America Imaging In Clinical Trials Market Size by Type (2022-2027)
    • 9.2.3 Latin America Imaging In Clinical Trials Market Size by Type (2016-2027)
  • 9.3 Latin America Imaging In Clinical Trials Market Size by End Users
    • 9.3.1 Latin America Imaging In Clinical Trials Market Size by End Users (2016-2021)
    • 9.3.2 Latin America Imaging In Clinical Trials Market Size by End Users (2022-2027)
    • 9.3.3 Latin America Imaging In Clinical Trials Market Size by End Users (2016-2027)
  • 9.4 Latin America Imaging In Clinical Trials Market Size by Country
    • 9.4.1 Latin America Imaging In Clinical Trials Market Size by Country (2016-2021)
    • 9.4.2 Latin America Imaging In Clinical Trials Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Imaging In Clinical Trials Market Size (2016-2027)
  • 10.2 Middle East & Africa Imaging In Clinical Trials Market Size by Type
    • 10.2.1 Middle East & Africa Imaging In Clinical Trials Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Imaging In Clinical Trials Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Imaging In Clinical Trials Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Imaging In Clinical Trials Market Size by End Users
    • 10.3.1 Middle East & Africa Imaging In Clinical Trials Market Size by End Users (2016-2021)
    • 10.3.2 Middle East & Africa Imaging In Clinical Trials Market Size by End Users (2022-2027)
    • 10.3.3 Middle East & Africa Imaging In Clinical Trials Market Size by End Users (2016-2027)
  • 10.4 Middle East & Africa Imaging In Clinical Trials Market Size by Country
    • 10.4.1 Middle East & Africa Imaging In Clinical Trials Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Imaging In Clinical Trials Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bioclinica
    • 11.1.1 Bioclinica Company Details
    • 11.1.2 Bioclinica Business Overview
    • 11.1.3 Bioclinica Imaging In Clinical Trials Introduction
    • 11.1.4 Bioclinica Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.1.5 Bioclinica Recent Development
  • 11.2 PAREXEL International Corporation
    • 11.2.1 PAREXEL International Corporation Company Details
    • 11.2.2 PAREXEL International Corporation Business Overview
    • 11.2.3 PAREXEL International Corporation Imaging In Clinical Trials Introduction
    • 11.2.4 PAREXEL International Corporation Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.2.5 PAREXEL International Corporation Recent Development
  • 11.3 Intrinsic Imaging
    • 11.3.1 Intrinsic Imaging Company Details
    • 11.3.2 Intrinsic Imaging Business Overview
    • 11.3.3 Intrinsic Imaging Imaging In Clinical Trials Introduction
    • 11.3.4 Intrinsic Imaging Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.3.5 Intrinsic Imaging Recent Development
  • 11.4 WorldCare Clinical, LLC
    • 11.4.1 WorldCare Clinical, LLC Company Details
    • 11.4.2 WorldCare Clinical, LLC Business Overview
    • 11.4.3 WorldCare Clinical, LLC Imaging In Clinical Trials Introduction
    • 11.4.4 WorldCare Clinical, LLC Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.4.5 WorldCare Clinical, LLC Recent Development
  • 11.5 ICON plc
    • 11.5.1 ICON plc Company Details
    • 11.5.2 ICON plc Business Overview
    • 11.5.3 ICON plc Imaging In Clinical Trials Introduction
    • 11.5.4 ICON plc Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.5.5 ICON plc Recent Development
  • 11.6 KEOSYS Medical Imaging
    • 11.6.1 KEOSYS Medical Imaging Company Details
    • 11.6.2 KEOSYS Medical Imaging Business Overview
    • 11.6.3 KEOSYS Medical Imaging Imaging In Clinical Trials Introduction
    • 11.6.4 KEOSYS Medical Imaging Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.6.5 KEOSYS Medical Imaging Recent Development
  • 11.7 MEDIAN Technologies
    • 11.7.1 MEDIAN Technologies Company Details
    • 11.7.2 MEDIAN Technologies Business Overview
    • 11.7.3 MEDIAN Technologies Imaging In Clinical Trials Introduction
    • 11.7.4 MEDIAN Technologies Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.7.5 MEDIAN Technologies Recent Development
  • 11.8 Navitas Life Sciences(TAKE Solutions)
    • 11.8.1 Navitas Life Sciences(TAKE Solutions) Company Details
    • 11.8.2 Navitas Life Sciences(TAKE Solutions) Business Overview
    • 11.8.3 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Introduction
    • 11.8.4 Navitas Life Sciences(TAKE Solutions) Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.8.5 Navitas Life Sciences(TAKE Solutions) Recent Development
  • 11.9 Mint Medical GmbH
    • 11.9.1 Mint Medical GmbH Company Details
    • 11.9.2 Mint Medical GmbH Business Overview
    • 11.9.3 Mint Medical GmbH Imaging In Clinical Trials Introduction
    • 11.9.4 Mint Medical GmbH Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.9.5 Mint Medical GmbH Recent Development
  • 11.10 Radiant Sage Ventures
    • 11.10.1 Radiant Sage Ventures Company Details
    • 11.10.2 Radiant Sage Ventures Business Overview
    • 11.10.3 Radiant Sage Ventures Imaging In Clinical Trials Introduction
    • 11.10.4 Radiant Sage Ventures Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.10.5 Radiant Sage Ventures Recent Development
  • 11.11 Resonance Health
    • 11.11.1 Resonance Health Company Details
    • 11.11.2 Resonance Health Business Overview
    • 11.11.3 Resonance Health Imaging In Clinical Trials Introduction
    • 11.11.4 Resonance Health Revenue in Imaging In Clinical Trials Business (2016-2021)
    • 11.11.5 Resonance Health Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Imaging In Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Imaging In Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End Users in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Services
    Software

    Segment by End Users
    Biotechnology Companies
    Pharmaceutical Companies
    Medical Device Manufacturers
    Government and Academic Institutions
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Bioclinica
    PAREXEL International Corporation
    Intrinsic Imaging
    WorldCare Clinical, LLC
    ICON plc
    KEOSYS Medical Imaging
    MEDIAN Technologies
    Navitas Life Sciences(TAKE Solutions)
    Mint Medical GmbH
    WorldCare Clinical, LLC


    Summary:
    Get latest Market Research Reports on Imaging In Clinical Trials. Industry analysis & Market Report on Imaging In Clinical Trials is a syndicated market report, published as Global Imaging In Clinical Trials Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Imaging In Clinical Trials market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,813.28
    4,219.92
    5,626.56
    3,260.93
    4,891.40
    6,521.87
    421,968.30
    632,952.45
    843,936.60
    284,952.72
    427,429.08
    569,905.44
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report